| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,198 |
3,928 |
$244K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,201 |
3,194 |
$229K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,530 |
3,236 |
$206K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
445 |
445 |
$33K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
395 |
377 |
$22K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
220 |
203 |
$12K |
| 99000 |
|
1,117 |
1,080 |
$11K |
| 81002 |
|
634 |
617 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
46 |
44 |
$407.10 |
| 71046 |
Radiologic examination, chest; 2 views |
14 |
14 |
$339.78 |
| 81025 |
|
97 |
93 |
$321.99 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
17 |
16 |
$250.86 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
96 |
93 |
$0.00 |